Protocol for Investigator Initiated Study: Glivec (imatinib mesylate) in systemic sclerosis, a pilot study.
Latest Information Update: 03 Sep 2021
At a glance
- Drugs Imatinib (Primary)
- Indications Systemic scleroderma
- Focus Therapeutic Use
- 03 Sep 2021 New trial record